Nautilus Biotechnology, Inc.

Healthcare · Biotechnology · United States

Last price 2.73 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 347.73M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to ...